Patents by Inventor Edward Nolan

Edward Nolan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240287176
    Abstract: The present disclosure is related to methods of treating an autoimmune disorder in a subject in need thereof comprising administering an immunoglobulin-like transcript 7 (ILT7) binding protein. The present disclosure also relates to methods of reducing plasmacytoid dendritic cells (pDCs), or reducing a type I interferon gene signature (IFNGS) in a tissue, of a subject in need thereof by administering an ILT7-binding protein to the subject.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 29, 2024
    Inventors: Jorn DRAPPA, John Nolan RATCHFORD, Edward R. HAMMOND, William A. REES, Gabor G. ILLEI, Li YAN
  • Publication number: 20210321744
    Abstract: A method of camouflaging a tonal imperfection comprising the steps of: identifying a skin tone of a user comprising a tonal imperfection; instructing the user to select a pigmented cosmetic composition adapted to camouflage the tonal imperfection based on the user's skin tone; selecting the pigmented cosmetic composition; and selectively targeting and depositing the pigmented cosmetic composition substantially only onto the tonal imperfection; wherein the pigmented cosmetic composition comprises an average composition L* value of about 10 to about 40 units greater than an average skin L* value of the user. The pigmented cosmetic composition can comprise a particular set of L*C*h* values such that when deposited onto tonal imperfections, it can result in natural, flawless looking skin, while still remaining substantially undetectable to the naked eye.
    Type: Application
    Filed: July 1, 2021
    Publication date: October 21, 2021
    Inventors: Janette Villalobos Lingoes, Thomas Elliot Rabe, Lissette D. Schorsch, Timothy Edward Nolan, Faiz Feisal Sherman, Stephan Gary Bush, Stephan James Andreas Meschkat
  • Patent number: 11076675
    Abstract: A method of camouflaging a tonal imperfection comprising the steps of: identifying a skin tone of a user comprising a tonal imperfection; instructing the user to select a pigmented cosmetic composition adapted to camouflage the tonal imperfection based on the user's skin tone; selecting the pigmented cosmetic composition; and selectively targeting and depositing the pigmented cosmetic composition substantially only onto the tonal imperfection; wherein the pigmented cosmetic composition comprises an average composition L* value of about 10 to about 40 units greater than an average skin L* value of the user. The pigmented cosmetic composition can comprise a particular set of L*C*h* values such that when deposited onto tonal imperfections, it can result in natural, flawless looking skin, while still remaining substantially undetectable to the naked eye.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: August 3, 2021
    Assignee: The Procter & Gamble Company
    Inventors: Janette Villalobos Lingoes, Thomas Elliot Rabe, Lissette D Schorsch, Timothy Edward Nolan, Faiz Feisal Sherman, Stephan Gary Bush, Stephan James Andreas Meschkat
  • Publication number: 20180360190
    Abstract: A method of camouflaging a tonal imperfection comprising the steps of: identifying a skin tone of a user comprising a tonal imperfection; instructing the user to select a pigmented cosmetic composition adapted to camouflage the tonal imperfection based on the user's skin tone; selecting the pigmented cosmetic composition; and selectively targeting and depositing the pigmented cosmetic composition substantially only onto the tonal imperfection; wherein the pigmented cosmetic composition comprises an average composition L* value of about 10 to about 40 units greater than an average skin L* value of the user. The pigmented cosmetic composition can comprise a particular set of L*C*h* values such that when deposited onto tonal imperfections, it can result in natural, flawless looking skin, while still remaining substantially undetectable to the naked eye.
    Type: Application
    Filed: June 13, 2018
    Publication date: December 20, 2018
    Inventors: Janette Villalobos Lingoes, Thomas Elliot Rabe, Lissette D. Schorsch, Timothy Edward Nolan, Faiz Feisal Sherman, Stephan Gary Bush, Stephan James Andreas Meschkat
  • Publication number: 20170153907
    Abstract: A management module of a managed computer is accessed via an out-or-band network. The management module communicates via a hypervisor with guest operating systems running in virtual machines on said managed computer.
    Type: Application
    Filed: December 1, 2015
    Publication date: June 1, 2017
    Inventors: Rajeev Grover, John Edward Nolan, Todd Joseph Kjos
  • Patent number: 9218356
    Abstract: Methods and systems for synchronizing network configuration state tables between an operating system kernel and an attached ASIC switch device are disclosed. An instruction to update a target network configuration state table in either an operating system kernel or an attached ASIC switch device is received. Data from the target network configuration state table and data from a corresponding network configuration state table are retrieved. Values of data in the two tables are compared and an instruction is sent to update the target network configuration state table with one or more values from the corresponding network configuration state table.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: December 22, 2015
    Assignee: Cumulus Networks, Inc.
    Inventors: Edward Nolan Leake, James Paul Rivers
  • Publication number: 20140214761
    Abstract: Methods and systems for synchronizing network configuration state tables between an operating system kernel and an attached ASIC switch device are disclosed. An instruction to update a target network configuration state table in either an operating system kernel or an attached ASIC switch device is received. Data from the target network configuration state table and data from a corresponding network configuration state table are retrieved. Values of data in the two tables are compared and an instruction is sent to update the target network configuration state table with one or more values from the corresponding network configuration state table.
    Type: Application
    Filed: January 31, 2013
    Publication date: July 31, 2014
    Applicant: Cumulus Networks, Inc.
    Inventors: Edward Nolan Leake, James Paul Rivers
  • Patent number: 7570992
    Abstract: In vivo methods are provided for using an electric field to delivery therapeutic treatment to a subject while reducing inducement of histopathological change in the target muscle tissue, such as is associated with induction or amplification of an immune response caused by the pulsed electric field. Therapeutic agents can be delivered nto cells of muscle for local and systemic treatments with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
    Type: Grant
    Filed: January 13, 2004
    Date of Patent: August 4, 2009
    Assignee: Genetronics, Inc.
    Inventors: Edward Nolan, Dietmar P. Rabussay, Georg Widera, Lei Zhang
  • Publication number: 20080271122
    Abstract: A control logic secures access to an electronic system. The control logic comprises an initialization logic and an operational logic. The initialization logic allocates access rights individually among a plurality of hardware and/or operation elements in the electronic system and individually secures the plurality of hardware and/or operation elements with electronic and/or software-activated access. The operational logic responds to attempted access by a user to authenticate hardware and/or operation elements and enable operation of the hardware and/or operation elements upon authentication.
    Type: Application
    Filed: April 27, 2007
    Publication date: October 30, 2008
    Inventors: John Edward Nolan, Rajeev Grover
  • Publication number: 20080115452
    Abstract: A prefabricated reinforced brick panel has a plurality of bricks arranged in a spaced-apart array with mortar between the bricks. The array comprises a number of superimposed rows of bricks. The bricks in each row are staggered relative to the bricks in each adjacent row of bricks. Each brick has a number of vertical through holes extending between a top and a bottom of the brick. These through holes are aligned in the array and vertical reinforcing bars are inserted into aligned holes and extend between a top and a bottom of the panel. Two offset vertical reinforcing bars pass through each brick. Transverse reinforcing bars are mounted in the mortar between rows of bricks.
    Type: Application
    Filed: November 2, 2007
    Publication date: May 22, 2008
    Inventor: Edward Nolan
  • Publication number: 20060224192
    Abstract: Improved devices and methods for performing electroporation-mediated delivery agents to cells is described. The method includes positioning a first electrode and a second electrode such that an electrical signal passed between the first electrode and the second electrode passes through the cell. The method also includes passing an electrical signal between the first electrode and the second electrode, the electrical signal having a frequency greater than about 10 kHz. In one embodiment of the method, the electrical signal has a bipolar waveform. In another embodiment of the method, the electrodes are positioned at a treatment site, e.g., a tumor, for in vivo delivery of an agent.
    Type: Application
    Filed: May 30, 2006
    Publication date: October 5, 2006
    Applicant: Genetronics, Inc.
    Inventors: Steve Dimmer, Gunter Hofmann, Daniel Holt, Gurvinder Nanda, Edward Nolan
  • Patent number: 6799163
    Abstract: In one embodiment the present invention provides a method for identity verification comprising the steps of: (a) comparing at least one first spoken voice print of a user speaking at least one piece of personal data against a first stored voice print of the user speaking said at least one piece of personal data; (b) comparing at least one second spoken voice print of the user speaking at least one piece of travel data against a second stored voice print of the user speaking said piece of travel data; and (c) determining if the user is a given individual based the results of step (a) and step (b).
    Type: Grant
    Filed: September 13, 2002
    Date of Patent: September 28, 2004
    Assignee: VAS International, Inc.
    Inventor: Marc Edward Nolan
  • Publication number: 20040147964
    Abstract: In vivo methods are provided for using an electric field to delivery therapeutic treatment to a subject while reducing inducement of histopathological change in the target muscle tissue, such as is associated with induction or amplification of an immune response caused by the pulsed electric field. Therapeutic agents can be delivered nto cells of muscle for local and systemic treatments with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
    Type: Application
    Filed: January 13, 2004
    Publication date: July 29, 2004
    Inventors: Edward Nolan, Dietmar P. Rabussay, Georg Widera, Lei Zhang
  • Publication number: 20040092860
    Abstract: The present invention describes an in vivo method, using pulsed electric field to deliver therapeutic agents into cells of the skin and muscle for local and systemic treatments. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
    Type: Application
    Filed: June 9, 2003
    Publication date: May 13, 2004
    Inventors: Nagendu B. Dev, Gunter A. Hofmann, Edward Nolan, Dietmar P. Rabussay, Arnt Tonnessen, Georg Widera, Lei Zhang
  • Patent number: 6697669
    Abstract: The present invention describes an in vivo method, using pulsed electric field to deliver therapeutic agents into cells of the skin and muscle for local and systemic treatments. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
    Type: Grant
    Filed: July 13, 1999
    Date of Patent: February 24, 2004
    Assignee: Genetronics, Inc.
    Inventors: Nagendu B. Dev, Gunter A. Hofmann, Edward Nolan, Dietmar P. Rabussay, Arnt Tonnessen, Georg Widera, Lei Zhang
  • Patent number: 6678556
    Abstract: In vivo methods are provided for using an electric field to delivery therapeutic treatment to a subject while reducing inducement of histopathological change in the target muscle tissue, such as is associated with induction or amplification of an immune response caused by the pulsed electric field. Therapeutic agents can be delivered nto cells of muscle for local and systemic treatments with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: January 13, 2004
    Assignee: Genetronics, Inc.
    Inventors: Edward Nolan, Dietmar P. Rabussay, Georg Widera, Lei Zhang
  • Publication number: 20030229492
    Abstract: In one embodiment the present invention provides a method for identity verification comprising the steps of: (a) comparing at least one first spoken voice print of a user speaking at least one piece of personal data against a first stored voice print of the user speaking said at least one piece of personal data; (b) comparing at least one second spoken voice print of the user speaking at least one piece of travel data against a second stored voice print of the user speaking said piece of travel data; and (c) determining if the user is a given individual based the results of step (a) and step (b).
    Type: Application
    Filed: September 13, 2002
    Publication date: December 11, 2003
    Inventor: Marc Edward Nolan
  • Patent number: 6654636
    Abstract: The present invention describes an in vivo method, using pulsed electric field to deliver therapeutic agents into cells of the skin and muscle for local and systemic treatments. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: November 25, 2003
    Assignee: Genetronics, Inc.
    Inventors: Nagendu B. Dev, Gunter A. Hofmann, Edward Nolan, Dietmar P. Rabussay, Arnt Tonnessen, Georg Widera, Lei Zhang
  • Publication number: 20020099323
    Abstract: The present invention describes an in vivo method, using pulsed electric field to deliver therapeutic agents into cells of the skin and muscle for local and systemic treatments. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
    Type: Application
    Filed: July 13, 1999
    Publication date: July 25, 2002
    Inventors: NAGENDU B. DEV, GUNTER A. HOFMANN, EDWARD NOLAN, DIETMAR P. RABUSSAY, ARNT TONNESSEN, GEORG WIDERA, LEI ZHANG
  • Patent number: 6424893
    Abstract: A mileage and fuel purchase monitoring device for vehicles including a data collecting system that is connected with an odometer of a truck or other motor vehicle. The data collecting system is preferably secured to a dashboard of the truck for easy access by the driver. The data collecting system is provided with a keyboard and a display for entering relevant information related to a planned trip to be made.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: July 23, 2002
    Inventors: Patrick Byrne, Edward Barnes, Edward Nolan